Medical Insurance Market By Age Group (Below 25, 25-34, 35-50, 50-64, 65 and Above), By Distribution Channel (Direct Sales, Brokers and Agents, Bancassurance, E-commerce), By Claim Type (Cashless Claims, Reimbursement Claims): Global Opportunity Analysis and Industry Forecast, 2024-2033
The global medical insurance market was valued at $1.7 trillion in 2023 and is estimated to reach $4.4 trillion by 2033, exhibiting a CAGR of 9.6% from 2024 to 2033. Medical insurance is a form of health coverage designed to help individuals manage the financial costs associated with medical care. It is a contract between an insurance provider and an individual, where the insurer agrees to cover a portion of medical expenses in exchange for regular premium payments. In addition, medical insurance includes a range of services such as doctor visits, hospital stays, surgeries, preventive care, and prescription medications. Medical insurance offered through various channels, including employer-sponsored plans, government programs such as Medicaid & Medicare, and individual plans purchased from insurance marketplaces.
The medical insurance market growth is primarily driven by rise in prevalence of chronic diseases, which has led to a higher utilization of medical services, including frequent doctor visits, hospitalizations, and ongoing treatments. This increased demand for healthcare services translates into higher costs for individuals and families, making insurance an essential safeguard against financial hardship, thus rise in prevalence of chronic diseases drives the medical insurance market growth. In addition, with rise in geriatric population, the demand for medical services grows, more individuals seek insurance to cover high medical expenses, which is expected to drive the medical insurance market expansion. However, complex policy terms and coverage limitations deter people from purchasing insurance, which hinders the medical insurance market growth. On the other hand, the expansion of insurance coverage to underserved and emerging markets provides an opportunity for market growth. As developing regions and underserved populations gain access to improved healthcare infrastructure, there is a rise in demand for insurance products tailored to these new markets. The expansion of insurance coverage is fueled by economic growth in emerging markets, which has led to the rise of a growing middle class. This increase enhances individuals' ability and willingness to invest in medical insurance. As the geriatric population becomes more financially secure, they seek insurance solutions to protect against the costs of medical care and improve their access to quality medical services, thereby supporting market growth.
The medical insurance market is segmented into age group, distribution channel, claim type, and region. By age group, it is classified into below 25, 25-34, 35-50, 50-64, and 65 and above. By distribution channel, it is divided into direct sales, brokers & agents, bancassurance, and e-commerce. By claim type, it is segregated into cashless claims and reimbursement claims. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the medical insurance market are BUPA, Medibank Private Limited, UnitedHealth Group, Aetna Inc., Allianz SE, AXA Group, Humana, Inc., Kaiser Foundation Health Plan, Inc., Ping An Insurance (Group) Company of China, Ltd., Zurich Insurance Company Ltd, Aviva, AIA Group, MetLife, Inc., Munich Re Group, The Cigna Group, and Anthem Insurance Companies, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which help to drive the growth of the medical insurance market globally.
Key Benefits For Stakeholders
By Age Group
The medical insurance market growth is primarily driven by rise in prevalence of chronic diseases, which has led to a higher utilization of medical services, including frequent doctor visits, hospitalizations, and ongoing treatments. This increased demand for healthcare services translates into higher costs for individuals and families, making insurance an essential safeguard against financial hardship, thus rise in prevalence of chronic diseases drives the medical insurance market growth. In addition, with rise in geriatric population, the demand for medical services grows, more individuals seek insurance to cover high medical expenses, which is expected to drive the medical insurance market expansion. However, complex policy terms and coverage limitations deter people from purchasing insurance, which hinders the medical insurance market growth. On the other hand, the expansion of insurance coverage to underserved and emerging markets provides an opportunity for market growth. As developing regions and underserved populations gain access to improved healthcare infrastructure, there is a rise in demand for insurance products tailored to these new markets. The expansion of insurance coverage is fueled by economic growth in emerging markets, which has led to the rise of a growing middle class. This increase enhances individuals' ability and willingness to invest in medical insurance. As the geriatric population becomes more financially secure, they seek insurance solutions to protect against the costs of medical care and improve their access to quality medical services, thereby supporting market growth.
The medical insurance market is segmented into age group, distribution channel, claim type, and region. By age group, it is classified into below 25, 25-34, 35-50, 50-64, and 65 and above. By distribution channel, it is divided into direct sales, brokers & agents, bancassurance, and e-commerce. By claim type, it is segregated into cashless claims and reimbursement claims. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the medical insurance market are BUPA, Medibank Private Limited, UnitedHealth Group, Aetna Inc., Allianz SE, AXA Group, Humana, Inc., Kaiser Foundation Health Plan, Inc., Ping An Insurance (Group) Company of China, Ltd., Zurich Insurance Company Ltd, Aviva, AIA Group, MetLife, Inc., Munich Re Group, The Cigna Group, and Anthem Insurance Companies, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which help to drive the growth of the medical insurance market globally.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical insurance market analysis from 2023 to 2033 to identify the prevailing medical insurance market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the medical insurance market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global medical insurance market trends, key players, market segments, application areas, and market growth strategies.
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- End user preferences and pain points
- Industry life cycle assessment, by region
- Product Benchmarking / Product specification and applications
- Product Life Cycles
- Senario Analysis & Growth Trend Comparision
- Technology Trend Analysis
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Pain Point Analysis
- Regulatory Guidelines
- Strategic Recommedations
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Brands Share Analysis
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Market share analysis of players at global/region/country level
- SWOT Analysis
By Age Group
- Below 25
- 25-34
- 35-50
- 50-64
- 65 and Above
- Direct Sales
- Brokers and Agents
- Bancassurance
- E-commerce
- Cashless Claims
- Reimbursement Claims
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- Key Market Players
- Aetna Inc.
- AIA Group
- Allianz SE
- Anthem Insurance Companies, Inc.
- Aviva
- AXA Group
- Bupa
- Humana, Inc.
- Kaiser Foundation Health Plan, Inc.
- Medibank Private Limited
- MetLife, Inc.
- Munich Re Group
- Ping An Insurance (Group) Company of China, Ltd.
- The Cigna Group
- UnitedHealth Group
- Zurich Insurance Company Ltd
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate to high bargaining power of suppliers
3.3.2. High to moderate threat of new entrants
3.3.3. Moderate to high threat of substitutes
3.3.4. Moderate to high intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in demand for insurance solutions
3.4.1.2. Increasing Awareness of Health and Wellness
3.4.1.3. Advancements in Medical Technology
3.4.2. Restraints
3.4.2.1. High Premium Costs and Affordability Issues
3.4.2.2. Regulatory Challenges and Compliance Costs
3.4.3. Opportunities
3.4.3.1. Digital Transformation and Telemedicine
3.5. Supply Demand Gap Analysis
3.6. Qualitative analysis on average medical insurance premium price
3.7. Qualitative analysis on detailed product Portfolio
CHAPTER 4: MEDICAL INSURANCE MARKET, BY AGE GROUP
4.1. Overview
4.1.1. Market size and forecast
4.2. Below
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. 25-34
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. 35-50
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. 50-64
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. 65 and Above
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: MEDICAL INSURANCE MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Direct Sales
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Brokers and Agents
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Bancassurance
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. E-commerce
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: MEDICAL INSURANCE MARKET, BY CLAIM TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Cashless Claims
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Reimbursement Claims
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: MEDICAL INSURANCE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Age Group
7.2.3. Market size and forecast, by Distribution Channel
7.2.4. Market size and forecast, by Claim Type
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Age Group
7.2.5.1.2. Market size and forecast, by Distribution Channel
7.2.5.1.3. Market size and forecast, by Claim Type
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Age Group
7.2.5.2.2. Market size and forecast, by Distribution Channel
7.2.5.2.3. Market size and forecast, by Claim Type
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Age Group
7.3.3. Market size and forecast, by Distribution Channel
7.3.4. Market size and forecast, by Claim Type
7.3.5. Market size and forecast, by country
7.3.5.1. UK
7.3.5.1.1. Market size and forecast, by Age Group
7.3.5.1.2. Market size and forecast, by Distribution Channel
7.3.5.1.3. Market size and forecast, by Claim Type
7.3.5.2. Germany
7.3.5.2.1. Market size and forecast, by Age Group
7.3.5.2.2. Market size and forecast, by Distribution Channel
7.3.5.2.3. Market size and forecast, by Claim Type
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Age Group
7.3.5.3.2. Market size and forecast, by Distribution Channel
7.3.5.3.3. Market size and forecast, by Claim Type
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Age Group
7.3.5.4.2. Market size and forecast, by Distribution Channel
7.3.5.4.3. Market size and forecast, by Claim Type
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Age Group
7.3.5.5.2. Market size and forecast, by Distribution Channel
7.3.5.5.3. Market size and forecast, by Claim Type
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Age Group
7.3.5.6.2. Market size and forecast, by Distribution Channel
7.3.5.6.3. Market size and forecast, by Claim Type
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Age Group
7.4.3. Market size and forecast, by Distribution Channel
7.4.4. Market size and forecast, by Claim Type
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Age Group
7.4.5.1.2. Market size and forecast, by Distribution Channel
7.4.5.1.3. Market size and forecast, by Claim Type
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Age Group
7.4.5.2.2. Market size and forecast, by Distribution Channel
7.4.5.2.3. Market size and forecast, by Claim Type
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Age Group
7.4.5.3.2. Market size and forecast, by Distribution Channel
7.4.5.3.3. Market size and forecast, by Claim Type
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Age Group
7.4.5.4.2. Market size and forecast, by Distribution Channel
7.4.5.4.3. Market size and forecast, by Claim Type
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Age Group
7.4.5.5.2. Market size and forecast, by Distribution Channel
7.4.5.5.3. Market size and forecast, by Claim Type
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Age Group
7.4.5.6.2. Market size and forecast, by Distribution Channel
7.4.5.6.3. Market size and forecast, by Claim Type
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Age Group
7.5.3. Market size and forecast, by Distribution Channel
7.5.4. Market size and forecast, by Claim Type
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by Age Group
7.5.5.1.2. Market size and forecast, by Distribution Channel
7.5.5.1.3. Market size and forecast, by Claim Type
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by Age Group
7.5.5.2.2. Market size and forecast, by Distribution Channel
7.5.5.2.3. Market size and forecast, by Claim Type
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by Age Group
7.5.5.3.2. Market size and forecast, by Distribution Channel
7.5.5.3.3. Market size and forecast, by Claim Type
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medibank Private Limited
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. UnitedHealth Group
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Aetna Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Allianz SE
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. AXA Group
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Humana, Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Bupa
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Kaiser Foundation Health Plan, Inc.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Ping An Insurance (Group) Company of China, Ltd.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Zurich Insurance Company Ltd
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.11. Aviva
9.11.1. Company overview
9.11.2. Key executives
9.11.3. Company snapshot
9.11.4. Operating business segments
9.11.5. Product portfolio
9.11.6. Business performance
9.12. AIA Group
9.12.1. Company overview
9.12.2. Key executives
9.12.3. Company snapshot
9.12.4. Operating business segments
9.12.5. Product portfolio
9.12.6. Business performance
9.13. MetLife, Inc.
9.13.1. Company overview
9.13.2. Key executives
9.13.3. Company snapshot
9.13.4. Operating business segments
9.13.5. Product portfolio
9.13.6. Business performance
9.14. Munich Re Group
9.14.1. Company overview
9.14.2. Key executives
9.14.3. Company snapshot
9.14.4. Operating business segments
9.14.5. Product portfolio
9.14.6. Business performance
9.15. The Cigna Group
9.15.1. Company overview
9.15.2. Key executives
9.15.3. Company snapshot
9.15.4. Operating business segments
9.15.5. Product portfolio
9.15.6. Business performance
9.15.7. Key strategic moves and developments
9.16. Anthem Insurance Companies, Inc.
9.16.1. Company overview
9.16.2. Key executives
9.16.3. Company snapshot
9.16.4. Operating business segments
9.16.5. Product portfolio
9.16.6. Business performance
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate to high bargaining power of suppliers
3.3.2. High to moderate threat of new entrants
3.3.3. Moderate to high threat of substitutes
3.3.4. Moderate to high intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in demand for insurance solutions
3.4.1.2. Increasing Awareness of Health and Wellness
3.4.1.3. Advancements in Medical Technology
3.4.2. Restraints
3.4.2.1. High Premium Costs and Affordability Issues
3.4.2.2. Regulatory Challenges and Compliance Costs
3.4.3. Opportunities
3.4.3.1. Digital Transformation and Telemedicine
3.5. Supply Demand Gap Analysis
3.6. Qualitative analysis on average medical insurance premium price
3.7. Qualitative analysis on detailed product Portfolio
CHAPTER 4: MEDICAL INSURANCE MARKET, BY AGE GROUP
4.1. Overview
4.1.1. Market size and forecast
4.2. Below
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. 25-34
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. 35-50
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. 50-64
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. 65 and Above
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: MEDICAL INSURANCE MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Direct Sales
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Brokers and Agents
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Bancassurance
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. E-commerce
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: MEDICAL INSURANCE MARKET, BY CLAIM TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Cashless Claims
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Reimbursement Claims
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: MEDICAL INSURANCE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Age Group
7.2.3. Market size and forecast, by Distribution Channel
7.2.4. Market size and forecast, by Claim Type
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Age Group
7.2.5.1.2. Market size and forecast, by Distribution Channel
7.2.5.1.3. Market size and forecast, by Claim Type
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Age Group
7.2.5.2.2. Market size and forecast, by Distribution Channel
7.2.5.2.3. Market size and forecast, by Claim Type
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Age Group
7.3.3. Market size and forecast, by Distribution Channel
7.3.4. Market size and forecast, by Claim Type
7.3.5. Market size and forecast, by country
7.3.5.1. UK
7.3.5.1.1. Market size and forecast, by Age Group
7.3.5.1.2. Market size and forecast, by Distribution Channel
7.3.5.1.3. Market size and forecast, by Claim Type
7.3.5.2. Germany
7.3.5.2.1. Market size and forecast, by Age Group
7.3.5.2.2. Market size and forecast, by Distribution Channel
7.3.5.2.3. Market size and forecast, by Claim Type
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Age Group
7.3.5.3.2. Market size and forecast, by Distribution Channel
7.3.5.3.3. Market size and forecast, by Claim Type
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Age Group
7.3.5.4.2. Market size and forecast, by Distribution Channel
7.3.5.4.3. Market size and forecast, by Claim Type
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Age Group
7.3.5.5.2. Market size and forecast, by Distribution Channel
7.3.5.5.3. Market size and forecast, by Claim Type
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Age Group
7.3.5.6.2. Market size and forecast, by Distribution Channel
7.3.5.6.3. Market size and forecast, by Claim Type
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Age Group
7.4.3. Market size and forecast, by Distribution Channel
7.4.4. Market size and forecast, by Claim Type
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Age Group
7.4.5.1.2. Market size and forecast, by Distribution Channel
7.4.5.1.3. Market size and forecast, by Claim Type
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Age Group
7.4.5.2.2. Market size and forecast, by Distribution Channel
7.4.5.2.3. Market size and forecast, by Claim Type
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Age Group
7.4.5.3.2. Market size and forecast, by Distribution Channel
7.4.5.3.3. Market size and forecast, by Claim Type
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Age Group
7.4.5.4.2. Market size and forecast, by Distribution Channel
7.4.5.4.3. Market size and forecast, by Claim Type
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Age Group
7.4.5.5.2. Market size and forecast, by Distribution Channel
7.4.5.5.3. Market size and forecast, by Claim Type
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Age Group
7.4.5.6.2. Market size and forecast, by Distribution Channel
7.4.5.6.3. Market size and forecast, by Claim Type
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Age Group
7.5.3. Market size and forecast, by Distribution Channel
7.5.4. Market size and forecast, by Claim Type
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by Age Group
7.5.5.1.2. Market size and forecast, by Distribution Channel
7.5.5.1.3. Market size and forecast, by Claim Type
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by Age Group
7.5.5.2.2. Market size and forecast, by Distribution Channel
7.5.5.2.3. Market size and forecast, by Claim Type
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by Age Group
7.5.5.3.2. Market size and forecast, by Distribution Channel
7.5.5.3.3. Market size and forecast, by Claim Type
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medibank Private Limited
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. UnitedHealth Group
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Aetna Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Allianz SE
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. AXA Group
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Humana, Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Bupa
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Kaiser Foundation Health Plan, Inc.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Ping An Insurance (Group) Company of China, Ltd.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Zurich Insurance Company Ltd
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.11. Aviva
9.11.1. Company overview
9.11.2. Key executives
9.11.3. Company snapshot
9.11.4. Operating business segments
9.11.5. Product portfolio
9.11.6. Business performance
9.12. AIA Group
9.12.1. Company overview
9.12.2. Key executives
9.12.3. Company snapshot
9.12.4. Operating business segments
9.12.5. Product portfolio
9.12.6. Business performance
9.13. MetLife, Inc.
9.13.1. Company overview
9.13.2. Key executives
9.13.3. Company snapshot
9.13.4. Operating business segments
9.13.5. Product portfolio
9.13.6. Business performance
9.14. Munich Re Group
9.14.1. Company overview
9.14.2. Key executives
9.14.3. Company snapshot
9.14.4. Operating business segments
9.14.5. Product portfolio
9.14.6. Business performance
9.15. The Cigna Group
9.15.1. Company overview
9.15.2. Key executives
9.15.3. Company snapshot
9.15.4. Operating business segments
9.15.5. Product portfolio
9.15.6. Business performance
9.15.7. Key strategic moves and developments
9.16. Anthem Insurance Companies, Inc.
9.16.1. Company overview
9.16.2. Key executives
9.16.3. Company snapshot
9.16.4. Operating business segments
9.16.5. Product portfolio
9.16.6. Business performance
